Oculeve
Latest round
- Series B
Last raised
- Mar 2014
Total raised
- $24M
Investors
- 3
About Oculeve
Oculeve, Inc.Founded in 2011, Oculeve, Inc. focuses on advanced therapeutic solutions for ocular health. The company was acquired by Allergan Inc in July 2015 for USD 125 mn. It is located in South San Francisco, US.Following its acquisition by Allergan, Oculeve's technologies are integrated within a diverse portfolio that addresses eye care needs, particularly for dry eye conditions.Oculeve generates revenue through Allergan's established channels, leveraging direct-to-consumer sales and B2B partnerships with healthcare providers.Post-acquisition, Oculeve's future growth is aligned with Allergan's strategic initiatives, which include launching new eye care products and expanding into new geographic markets. The acquisition deal in July 2015 will allow Allergan to utilize the USD 125 mn investment to enhance R&D efforts in developing innovative therapies for ocular health.
Who invested in Oculeve
3 investors across 2 rounds
See all investors in Oculeve
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Oculeve
Who invested in Oculeve?
Oculeve has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oculeve raised?
Oculeve has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Oculeve last raise money?
Oculeve's most recent round on record is a Series B, in Mar 2014.
What does Oculeve do?
Oculeve is a biotechnology company.
Where is Oculeve headquartered?
Oculeve is headquartered in South San Francisco, US.
Which VCs invest in companies like Oculeve?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Oculeve's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Oculeve? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.